Hallux patch during anti-transcription intermediary factor-1γ dermatomyositis

被引：0
|
作者：
Kluger, Nicolas [1 ,2 ]
机构：
[1] Univ Helsinki, Dept Dermatol Allergol & Venereol, Helsinki, Finland
[2] Helsinki Univ Hosp, Helsinki, Finland
来源：
CLINICAL AND EXPERIMENTAL DERMATOLOGY | 2024年 / 49卷 / 10期
关键词：
ANTIBODIES;
D O I：
10.1093/ced/llae142
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
This case illustrates that the hallux patch sign, among others, is not restricted to anti-MDA5 dermatomyositis.
引用
收藏
页码：1246 / 1247
页数：2
相关论文
共 50 条
  • [31] Expression of the Dermatomyositis Autoantigen Transcription Intermediary Factor 1γ in Regenerating Muscle
    Mohassel, Payam
    Rosen, Paul
    Casciola-Rosen, Livia
    Pak, Katherine
    Mammen, Andrew L.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67 (01) : 266 - 272
  • [32] Case report of anti-transcription intermediary factor-1-γ/α antibody-positive dermatomyositis associated with gastric cancer and immunoglobulin G4-positive pulmonary inflammatory pseudotumor
    Ito, Kotaro
    Imafuku, Shinichi
    Hamaguchi, Yasuhito
    Fujimoto, Manabu
    Nakayama, Juichiro
    JOURNAL OF DERMATOLOGY, 2013, 40 (07): : 567 - 569
  • [33] Authors' reply to "a case of juvenile amyopathic dermatomyositis with anti-transcription intermediary factor 1-α antibody showing negative anti-TIF1-γ ELISA results: Comment on the article by Mizumaki et al."
    Matsushita, Takashi
    Fushida, Natsumi
    Horii, Motoki
    Mizumaki, Kie
    JOURNAL OF DERMATOLOGY, 2023, 50 (07): : E228 - E229
  • [34] Anti-transcription intermediate factor 1-γ antibody-positive dermatomyositis with refractory skin ulcers and rapid cancer progression
    Yamamoto, Rika
    Kokubu, Hiraku
    Ikuno, Yasuaki
    Kato, Miwa
    Koike, Takahiro
    Takahashi, Toshifumi
    Fujimoto, Noriki
    JOURNAL OF DERMATOLOGY, 2025, 52 (03): : e229 - e230
  • [35] Anti-Transcription Factor RNA Aptamers as Potential Therapeutics
    Mondragon, Estefania
    Maher, Louis James, III
    NUCLEIC ACID THERAPEUTICS, 2016, 26 (01) : 29 - 43
  • [36] Small cell lung cancer and interstitial pneumonia associated with anti-transcriptional intermediary factor-1γ-positive dermatomyositis
    Kato, Toshio
    Ito, Satoru
    Tsuzuki, Toyonori
    Watanabe, Daisuke
    Kubo, Akihito
    Yamaguchi, Etsuro
    RESPIROLOGY CASE REPORTS, 2019, 7 (04):
  • [37] Presence of anti-transcriptional intermediary factor-1 gamma antibodies in a dermatomyositis patient with retroperitoneal cancer of unknown primary site
    Hori, Hiroshi
    Ozeki, Yusuke
    Kobashigawa, Tsuyoshi
    Futsuhara, Kazusige
    Tanaka, Akira
    Watanabe, Eri
    Yabe, Hiroki
    Yago, Toru
    Fukuchi, Takahiko
    Sugawara, Hitoshi
    Kotake, Shigeru
    MODERN RHEUMATOLOGY CASE REPORTS, 2021, 5 (01) : 62 - 68
  • [38] Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ antibodies in adults with dermatomyositis
    Fiorentino, David F.
    Kuo, Karen
    Chung, Lorinda
    Zaba, Lisa
    Li, Shufeng
    Casciola-Rosen, Livia
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (03) : 449 - 455
  • [39] Enzyme-linked immunosorbent assays for detection of anti-transcriptional intermediary factor-1 gamma and anti-Mi-2 autoantibodies in dermatomyositis
    Fujimoto, Manabu
    Murakami, Akihiro
    Kurei, Shunsuke
    Okiyama, Naoko
    Kawakami, Atsushi
    Mishima, Michiaki
    Sato, Shinji
    Seishima, Mariko
    Suda, Takafumi
    Mimori, Tsuneyo
    Takehara, Kazuhiko
    Kuwana, Masataka
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2016, 84 (03) : 272 - 281
  • [40] SCLC, Paraneoplastic Dermatomyositis, Positive Transcription Intermediary Factor 1-y, and Point Mutation in the Transcription Intermediary Factor 1-y Coding Gene: A Case Report
    Arnon, Johnathan
    Elia, Anna
    Nevo, Yuval
    Lossos, Alexander
    Nechushtan, Hovav
    JTO CLINICAL AND RESEARCH REPORTS, 2021, 2 (09):
12345